Sign in

CIK 0001055726

  • Non-accelerated filer
  • Smaller reporting company

INOVIO PHARMACEUTICALS, INC.

Sign in to watch
Ticker
INO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330969592
Phone
+1 858-410-3134
Business address
660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
Former names
INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-03-09 Weiner David B. Director Exercise or conversion · Restricted Stock Unit −10,000 20,000
2017-03-06 Sardesai Niranjan Chief Operating Officer Shares withheld for taxes −3,067 $6.95 $21K 63,513
2017-03-06 KIES PETER CFO Shares withheld for taxes −3,640 $6.95 $25K 31,219
2017-03-06 Bagarazzi Mark Chief Medical Officer Shares withheld for taxes −3,067 $6.95 $21K 25,758
2017-03-06 Kim Jong Joseph Chief Executive Officer Shares withheld for taxes −4,365 $6.95 $30K 1,964,610
2017-03-05 Sardesai Niranjan Chief Operating Officer Exercise or conversion +8,333 66,580
2017-03-05 Sardesai Niranjan Chief Operating Officer Exercise or conversion · Restricted Stock Unit −8,333 8,333
2017-03-05 KIES PETER CFO Exercise or conversion +8,333 34,859
2017-03-05 KIES PETER CFO Exercise or conversion · Restricted Stock Unit −8,333 8,333
2017-03-05 Bagarazzi Mark Chief Medical Officer Exercise or conversion +8,333 28,825
2017-03-05 Bagarazzi Mark Chief Medical Officer Exercise or conversion · Restricted Stock Unit −8,333 8,333
2017-03-05 Kim Jong Joseph Chief Executive Officer Exercise or conversion +13,333 1,968,975
2017-03-05 Kim Jong Joseph Chief Executive Officer Exercise or conversion · Restricted Stock Unit −13,333 13,333
2017-01-04 Sardesai Niranjan Chief Operating Officer Exercise or conversion +6,133 $6.12 $38K 54,567
2017-01-04 Sardesai Niranjan Chief Operating Officer Exercise or conversion +3,680 $6.12 $23K 58,247
2017-01-04 Sardesai Niranjan Chief Operating Officer Exercise or conversion · Common Stock Option −6,133 0
2017-01-04 Sardesai Niranjan Chief Operating Officer Exercise or conversion · Common Stock Option −3,680 0
2016-08-29 Sardesai Niranjan Chief Operating Officer Sale −21,800 $9.30 $203K 48,434
2016-08-28 Sardesai Niranjan Chief Operating Officer Exercise or conversion +33,116 $6.12 $203K 70,234
2016-08-28 Sardesai Niranjan Chief Operating Officer Exercise or conversion · Common Stock Options −33,116 0

Page 47 of 49 · 961 trades